Buparlisib Active Not Recruiting Phase 3 Trials for Head And Neck Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04338399The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC